Financials
- Market Capitalization 478.97 M
- Employee 67
- Founded 2012
- CEO N/A
- Website www.prothena.com
- Headquarter Ireland
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-11.8
Relación precio/flujo de caja
8.07
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2937 | EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -4.24% | +0.64% | +18.80% | +25.40% | 485.31 M USD | ||
| 2943 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.36% | +17.83% | -23.67% | 479.78 M USD | ||
| 2954 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.02% | +5.19% | +49.81% | 473.65 M USD | ||
| 2959 | PBYI Puma Biotechnology Inc - Common Stock | 9.06 USD | -1.95% | -2.58% | +15.41% | +79.41% | 467.68 M USD |